Ekansh Seth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ekansh Seth has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- John LaRocco
Ronin Institute for Independent Scholarship 2.0, Sacramento, CA 95816, USA
4 shared publications - Anna Bontempo
Electrical and Computer Engineering, Ohio State University, Columbus, OH 43210, USA
1 shared publication - Brian Minnick
Massachusetts Institute of Technology, USA
1 shared publication - Eric Zachariah
College of Arts and Sciences, The Ohio State University, Columbus, OH 43210, USA
1 shared publication - Gretchen A. McNally
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at The Ohio State University, Columbus, OH, USA
1 shared publication - Jane Ginther
The Ohio State Wexner Medical Center Addiction Medicine Team, Columbus, OH, USA
1 shared publication
Latest Publications
- Open Access
- 1 November 2026
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 19, 1-7
Perceptions of Equitable Care and Bias Among Multidisciplinary Healthcare Professionals: A Secondary Analysis of Two Surveys
Stigma towards people with opioid use disorders (OUD) contributes to delayed treatment, dismissed concerns, and reduced equitable care. Although healthcare professionals may recognize these harms, they often underestimate their own susceptibility to bias. Prior studies have primarily focused on addiction-related stigma within individual professions rather than across multidisciplinary teams. The current study compares responses from two studies conducted at The Ohio State University Wexner Medical Center. Study A (2020) included multidisciplinary oncology professionals (n = 773), while Study B (2023) comprised rehabilitation professionals (n = 93), with 42 respondents completing the focal items on the post-intervention evaluation. Both studies assessed agreement with two statements: (1) “I am certain I treat all persons the same, regardless of current or past OUD”, and (2) “In today’s society, I am certain that stereotypes or bias do not impact the quality of care patients receive”. Across the studies, most respondents agreed or strongly agreed that they treat all patients the same regardless of OUD history (Study A: 64.7%, n = 468/723; Study B: 73.8%, n = 31/42), while 22.3% and 14.3% selected neutral, respectively. For the second item, 48.1% of Study A respondents (346/719) and 78.6% of Study B respondents (33/42) disagreed or strongly disagreed that stereotypes or bias do not impact the quality of care patients receive. These findings suggest a gap between clinicians’ confidence in their own equitable treatment and their recognition that bias may influence care. Future research should explore interventions pairing OUD education with structured self-reflection and narrative-based approaches from people in recovery, alongside the development of validated measures of provider bias awareness to support sustained reflective practice across disciplines.
- 1 November 2026
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 19, 1-7
Open AccessPerceptions of Equitable Care and Bias Among Multidisciplinary Healthcare Professionals: A Secondary Analysis of Two Surveys
Stigma towards people with opioid use disorders (OUD) contributes to delayed treatment, dismissed concerns, and reduced equitable care. Although healthcare professionals may recognize these harms, they often underestimate their own susceptibility to bias. Prior studies have primarily focused on addiction-related stigma within individual professions rather than across multidisciplinary teams. The current study compares responses from two studies conducted at The Ohio State University Wexner Medical Center. Study A (2020) included multidisciplinary oncology professionals (n = 773), while Study B (2023) comprised rehabilitation professionals (n = 93), with 42 respondents completing the focal items on the post-intervention evaluation. Both studies assessed agreement with two statements: (1) “I am certain I treat all persons the same, regardless of current or past OUD”, and (2) “In today’s society, I am certain that stereotypes or bias do not impact the quality of care patients receive”. Across the studies, most respondents agreed or strongly agreed that they treat all patients the same regardless of OUD history (Study A: 64.7%, n = 468/723; Study B: 73.8%, n = 31/42), while 22.3% and 14.3% selected neutral, respectively. For the second item, 48.1% of Study A respondents (346/719) and 78.6% of Study B respondents (33/42) disagreed or strongly disagreed that stereotypes or bias do not impact the quality of care patients receive. These findings suggest a gap between clinicians’ confidence in their own equitable treatment and their recognition that bias may influence care. Future research should explore interventions pairing OUD education with structured self-reflection and narrative-based approaches from people in recovery, alongside the development of validated measures of provider bias awareness to support sustained reflective practice across disciplines.
- Open Access
- 8 October 2026
- Published by MDPI AG in Industries
- Vol. 1 (2) , 11
Pre-Pilot Formulation Scouting of Viscoelastic Fluid–Foam Composites for Audio-Frequency Acoustic Transmission Screening: A Descriptive Ranking Study with Stage-Gate and Pre-QbD Roadmaps
Medical ultrasound transducers require acoustic impedance matching layers to bridge the gap between piezoelectric ceramics (~30–38 MRayl) and biological tissue (~1.5–1.7 MRayl). Existing solutions—such as alumina–epoxy, anodic aluminum oxide–epoxy 1–3 composites, magnesium alloys, and gradient nanocomposites—rely on high-temperature curing, precision machining, or multi-step fabrication, which increase production costs and limit design flexibility. Viscoelastic suspensions offer a potential low-cost alternative, but prior to any clinical assessment, manufacturing protocols must be bounded at the exploratory stage. This study does not demonstrate impedance matching, quarter-wavelength performance, or immediate clinical relevance. This work defines a Stage 1 pre-pilot (Technology Readiness Level 2–3) exploratory study to bound manufacturing protocols, rank formulations, and identify candidate parameters for future Quality by Design implementation. Six formulations were tested in open-cell polyurethane foam matrix: thick cornstarch–water (50:50 wt%), thin cornstarch–water (66:33 wt%), polystyrene sulfonate (50:50 wt%), polyethylene glycol–fumed silica (40:60 wt%), boric acid–simethicone, and a boric acid–cornstarch hybrid. The 5 mm prototypes function as bulk composite samples rather than functional matching layers, and all testing was performed at audio frequencies (50 Hz–20 kHz) with uncalibrated consumer-grade instrumentation. At 50–1000 Hz, boric acid–simethicone exhibited the lowest attenuation (32 dB). At 10,000–20,000 Hz, polystyrene sulfonate and thin cornstarch showed the lowest attenuation (97 dB at 20 kHz). Attenuation increased with frequency; a dip between 100 and 1000 Hz was attributed to fixture interference. Two independent recordings were obtained per condition (n = 2). No inferential statistics, confidence intervals, or variance estimates were computed. The results establish a descriptive baseline but do not demonstrate impedance matching or immediate clinical relevance; the 5 mm prototypes function as bulk composite samples rather than quarter-wavelength matching layers. Should subsequent high-frequency validation prove promising, future work includes factorial or definitive screening designs, hydrophone calibration per international standards, Z = ρc measurements, substrate deconvolution, 0.5–1.0 mm layers for 650 kHz, phantom validation, and ISO 10993 biocompatibility screening.
- 8 October 2026
- Published by MDPI AG in Industries
- Vol. 1 (2) , 11
Open AccessPre-Pilot Formulation Scouting of Viscoelastic Fluid–Foam Composites for Audio-Frequency Acoustic Transmission Screening: A Descriptive Ranking Study with Stage-Gate and Pre-QbD Roadmaps
Medical ultrasound transducers require acoustic impedance matching layers to bridge the gap between piezoelectric ceramics (~30–38 MRayl) and biological tissue (~1.5–1.7 MRayl). Existing solutions—such as alumina–epoxy, anodic aluminum oxide–epoxy 1–3 composites, magnesium alloys, and gradient nanocomposites—rely on high-temperature curing, precision machining, or multi-step fabrication, which increase production costs and limit design flexibility. Viscoelastic suspensions offer a potential low-cost alternative, but prior to any clinical assessment, manufacturing protocols must be bounded at the exploratory stage. This study does not demonstrate impedance matching, quarter-wavelength performance, or immediate clinical relevance. This work defines a Stage 1 pre-pilot (Technology Readiness Level 2–3) exploratory study to bound manufacturing protocols, rank formulations, and identify candidate parameters for future Quality by Design implementation. Six formulations were tested in open-cell polyurethane foam matrix: thick cornstarch–water (50:50 wt%), thin cornstarch–water (66:33 wt%), polystyrene sulfonate (50:50 wt%), polyethylene glycol–fumed silica (40:60 wt%), boric acid–simethicone, and a boric acid–cornstarch hybrid. The 5 mm prototypes function as bulk composite samples rather than functional matching layers, and all testing was performed at audio frequencies (50 Hz–20 kHz) with uncalibrated consumer-grade instrumentation. At 50–1000 Hz, boric acid–simethicone exhibited the lowest attenuation (32 dB). At 10,000–20,000 Hz, polystyrene sulfonate and thin cornstarch showed the lowest attenuation (97 dB at 20 kHz). Attenuation increased with frequency; a dip between 100 and 1000 Hz was attributed to fixture interference. Two independent recordings were obtained per condition (n = 2). No inferential statistics, confidence intervals, or variance estimates were computed. The results establish a descriptive baseline but do not demonstrate impedance matching or immediate clinical relevance; the 5 mm prototypes function as bulk composite samples rather than quarter-wavelength matching layers. Should subsequent high-frequency validation prove promising, future work includes factorial or definitive screening designs, hydrophone calibration per international standards, Z = ρc measurements, substrate deconvolution, 0.5–1.0 mm layers for 650 kHz, phantom validation, and ISO 10993 biocompatibility screening.
- Open Access
- 10 July 2026
- Published by MDPI AG in Preprints.org
Pre-Pilot Formulation Scouting of Viscoelastic Fluid–Foam Composites for Acoustic Transmission Screening: A Descriptive Ranking Study at Audio Frequencies with Stage-Gate and Pre-QbD Roadmaps
Medical ultrasound transducers require acoustic impedance matching layers to bridge the gap between piezoelectric ceramics (~30–38 MRayl) and biological tissue (~1.5–1.7 MRayl). Existing solutions—such as alumina–epoxy, anodic aluminum oxide–epoxy 1–3 composites, magnesium alloys, and gradient nanocomposites—rely on high-temperature curing, precision machining, or multi-step fabrication, which increase production costs and limit design flexibility. Viscoelastic suspensions offer a low-cost alternative, but lack process integration data. This work defines a Stage 1 pre-pilot (Technology Readiness Level 2–3) exploratory study to bound manufacturing protocols, rank formulations, and identify candidate parameters for future Quality by Design implementation. Six formulations were tested in open-cell polyurethane foam matrix: thick cornstarch–water (50:50 wt%), thin cornstarch–water (66:33 wt%), polystyrene sulfonate (50:50 wt%), polyethylene glycol–fumed silica (40:60 wt%), boric acid–simethicone, and a boric acid–cornstarch hybrid. Prototypes were 7 cm in diameter and 5 mm thick. An underwater transmission setup using a polyethylene bag fixture and consumer earbuds recorded sine tones at 50 Hz, 100 Hz, 1 kHz, 10 kHz, and 20 kHz (n = 2), and the relative insertion loss was compared against controls. At 50–1000 Hz, boric acid–simethicone exhibited the lowest attenuation (32 dB). At 10,000–20,000 Hz, polystyrene sulfonate and thin cornstarch showed the lowest attenuation (97 dB at 20 kHz). Attenuation increased with frequency; a dip between 100 and 1,000 Hz was attributed to fixture interference. No statistical analysis was performed owing to the small sample size (n = 2) and uncalibrated instrumentation. The results establish a descriptive baseline but do not demonstrate impedance matching or immediate clinical relevance; the 5 mm prototypes function as bulk composite samples rather than quarter-wavelength matching layers. Future work includes factorial or definitive screening designs, hydrophone calibration per international standards [21], Z = ρc measurements, substrate deconvolution, 0.5–1.0 mm layers for 650 kHz, phantom validation, and ISO 10993 biocompatibility screening.
- 10 July 2026
- Published by MDPI AG in Preprints.org
Open AccessPre-Pilot Formulation Scouting of Viscoelastic Fluid–Foam Composites for Acoustic Transmission Screening: A Descriptive Ranking Study at Audio Frequencies with Stage-Gate and Pre-QbD Roadmaps
Medical ultrasound transducers require acoustic impedance matching layers to bridge the gap between piezoelectric ceramics (~30–38 MRayl) and biological tissue (~1.5–1.7 MRayl). Existing solutions—such as alumina–epoxy, anodic aluminum oxide–epoxy 1–3 composites, magnesium alloys, and gradient nanocomposites—rely on high-temperature curing, precision machining, or multi-step fabrication, which increase production costs and limit design flexibility. Viscoelastic suspensions offer a low-cost alternative, but lack process integration data. This work defines a Stage 1 pre-pilot (Technology Readiness Level 2–3) exploratory study to bound manufacturing protocols, rank formulations, and identify candidate parameters for future Quality by Design implementation. Six formulations were tested in open-cell polyurethane foam matrix: thick cornstarch–water (50:50 wt%), thin cornstarch–water (66:33 wt%), polystyrene sulfonate (50:50 wt%), polyethylene glycol–fumed silica (40:60 wt%), boric acid–simethicone, and a boric acid–cornstarch hybrid. Prototypes were 7 cm in diameter and 5 mm thick. An underwater transmission setup using a polyethylene bag fixture and consumer earbuds recorded sine tones at 50 Hz, 100 Hz, 1 kHz, 10 kHz, and 20 kHz (n = 2), and the relative insertion loss was compared against controls. At 50–1000 Hz, boric acid–simethicone exhibited the lowest attenuation (32 dB). At 10,000–20,000 Hz, polystyrene sulfonate and thin cornstarch showed the lowest attenuation (97 dB at 20 kHz). Attenuation increased with frequency; a dip between 100 and 1,000 Hz was attributed to fixture interference. No statistical analysis was performed owing to the small sample size (n = 2) and uncalibrated instrumentation. The results establish a descriptive baseline but do not demonstrate impedance matching or immediate clinical relevance; the 5 mm prototypes function as bulk composite samples rather than quarter-wavelength matching layers. Future work includes factorial or definitive screening designs, hydrophone calibration per international standards [21], Z = ρc measurements, substrate deconvolution, 0.5–1.0 mm layers for 650 kHz, phantom validation, and ISO 10993 biocompatibility screening.
- Open Access
- 13 October 2025
- Published by MDPI AG in Preprints.org
3D Printed Control and Actuation for Distributed Manufacturing and Self-Replication
We report on the first open-source FDM 3D printer capable of fabricating its complete electromechanical ecosystem—motors, solenoids, memory systems, and control elements—representing a fundamental advance toward true mechanical self-replication. While previous self-replicating printers produced only structural components, our platform manufactures functional electronics comparable to commercial counterparts: solenoid actuators matching conventional benchmarks (108 ± 5 μJ vs. 99 ± 1.5 μJ), a three-pole brushed DC motor with performance paralleling commercial units, and dual memory architectures: functional mechanical (1639 bits/g) and developmental magnetic systems with theoretical density (5468 bits/g) encoding. The critical innovation lies not in individual components but in their integration within a single fabrication ecosystem, where printed memory directly controls printed actuators without external electronics. Using only standard FDM hardware and accessible materials, we demonstrate that low-cost printers can produce the control, storage, and motion subsystems necessary for autonomous operation. This work establishes that self-sustaining manufacturing—where machines reproduce their own functional components—is achievable with existing additive manufacturing technology, with profound implications for distributed production, space exploration, and resilient supply chains.
- 13 October 2025
- Published by MDPI AG in Preprints.org
Open Access3D Printed Control and Actuation for Distributed Manufacturing and Self-Replication
We report on the first open-source FDM 3D printer capable of fabricating its complete electromechanical ecosystem—motors, solenoids, memory systems, and control elements—representing a fundamental advance toward true mechanical self-replication. While previous self-replicating printers produced only structural components, our platform manufactures functional electronics comparable to commercial counterparts: solenoid actuators matching conventional benchmarks (108 ± 5 μJ vs. 99 ± 1.5 μJ), a three-pole brushed DC motor with performance paralleling commercial units, and dual memory architectures: functional mechanical (1639 bits/g) and developmental magnetic systems with theoretical density (5468 bits/g) encoding. The critical innovation lies not in individual components but in their integration within a single fabrication ecosystem, where printed memory directly controls printed actuators without external electronics. Using only standard FDM hardware and accessible materials, we demonstrate that low-cost printers can produce the control, storage, and motion subsystems necessary for autonomous operation. This work establishes that self-sustaining manufacturing—where machines reproduce their own functional components—is achievable with existing additive manufacturing technology, with profound implications for distributed production, space exploration, and resilient supply chains.
- Open Access
- 20 July 2024
- Published by MDPI AG in Applied Sciences
- Vol. 14 (14) , 6328
Evaluating Commercial Electrical Neuromodulation Devices with Low-Cost Neural Phantoms
Non-invasive transcranial electrical stimulation is a category of neuromodulation techniques used for various disorders. Although medically approved devices exist, the variety of consumer electrical stimulation devices is increasing. Because clinical trials and animal tests are costly and risky, using a brain phantom can provide preliminary experimental validation. However, existing brain phantoms are often costly or require excessive preparation time, precluding their use for rapid, real-time optimization of stimulation settings. A limitation of direct electric fields in a phantom is the lack of 3D spatial resolution. Using well-researched modalities such as transcranial direct current stimulation (tDCS) and newer modalities such as amplitude-modulated transcranial pulsed-current stimulation (am-tPCS), a range of materials was tested for use as electrical phantoms. Based on cost, preparation time, and efficiency, ground beef and agar gel with a 10% salt mix were selected. The measured values for the total dosages were 0.55 W-s for am-tPCS and 0.91 W-s for tDCS. Due to a low gain on the recording electrodes, the signal efficiency measured against the power delivered was 4.2% for tDCS and 3.1% for am-tPCS. Issues included electrodes shifting in the soft material and the low sensitivity of the recording electrodes. Despite these issues, the effective combination of the phantom and recording methodologies can enable low costs and the rapid testing, experimentation, and verification of consumer neuromodulation devices in three dimensions. Additionally, the efficiency factors (EFs) between the observed dosage and the delivered dosage could streamline the comparison of experimental configurations. As demonstrated by comparing two types of electrical neuromodulation devices across the 3D space of a phantom, EFs can be used in conjunction with a cost-effective, time-expedient phantom to rapidly iterate and optimize stimulation parameters.
- 20 July 2024
- Published by MDPI AG in Applied Sciences
- Vol. 14 (14) , 6328
Open AccessEvaluating Commercial Electrical Neuromodulation Devices with Low-Cost Neural Phantoms
Non-invasive transcranial electrical stimulation is a category of neuromodulation techniques used for various disorders. Although medically approved devices exist, the variety of consumer electrical stimulation devices is increasing. Because clinical trials and animal tests are costly and risky, using a brain phantom can provide preliminary experimental validation. However, existing brain phantoms are often costly or require excessive preparation time, precluding their use for rapid, real-time optimization of stimulation settings. A limitation of direct electric fields in a phantom is the lack of 3D spatial resolution. Using well-researched modalities such as transcranial direct current stimulation (tDCS) and newer modalities such as amplitude-modulated transcranial pulsed-current stimulation (am-tPCS), a range of materials was tested for use as electrical phantoms. Based on cost, preparation time, and efficiency, ground beef and agar gel with a 10% salt mix were selected. The measured values for the total dosages were 0.55 W-s for am-tPCS and 0.91 W-s for tDCS. Due to a low gain on the recording electrodes, the signal efficiency measured against the power delivered was 4.2% for tDCS and 3.1% for am-tPCS. Issues included electrodes shifting in the soft material and the low sensitivity of the recording electrodes. Despite these issues, the effective combination of the phantom and recording methodologies can enable low costs and the rapid testing, experimentation, and verification of consumer neuromodulation devices in three dimensions. Additionally, the efficiency factors (EFs) between the observed dosage and the delivered dosage could streamline the comparison of experimental configurations. As demonstrated by comparing two types of electrical neuromodulation devices across the 3D space of a phantom, EFs can be used in conjunction with a cost-effective, time-expedient phantom to rapidly iterate and optimize stimulation parameters.